Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04504812 · ClinicalTrials.gov registry record · Phase 3
A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain
A Phase 3 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,937
- Enrollment target
NCT04504812: Completed Phase 3 study, sponsored by Johns Hopkins University.
NCT04504812 is a Phase 3 study that has completed, run by Johns Hopkins University. The registered enrollment target is 1,937 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04504812, a Phase 3 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,937 participants
- Enrollment target
Study Summary
There is an urgent public health need to reduce reliance on opioids for effective long-term pain management, particularly in knee osteoarthritis (KOA). This effectiveness trial will compare commonly recommended treatments to reduce pain and functional limitations in KOA.These results will lead to improved patient selection for treatment and inform evidence based guidelines by offering well-tested, effective, non-surgical alternatives.
Interventions
- DRUG Duloxetine
- COMBINATION_PRODUCT Intra-Articular Injection
- PROCEDURE Nerve Procedure with long acting blocks
- PROCEDURE Nerve Procedure with nerve ablation
- BEHAVIORAL Pain Coping Skills Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,937 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2025-04-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04504812
The ClinicalTrials.gov registry entry for NCT04504812 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,937 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Duloxetine is the first listed.
NCT04504812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04504812 about?
NCT04504812 is a clinical study titled "A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain". There is an urgent public health need to reduce reliance on opioids for effective long-term pain management, particularly in knee osteoarthritis (KOA). This effectiveness trial will compare commonly recommended treatments to reduce pain and functional limitations in KOA.These results will lead to im...
What is the current status of trial NCT04504812?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,937 participants. The study started on 2021-02-01. Estimated completion is 2025-04-08.
What interventions are being tested in trial NCT04504812?
The interventions under investigation include: Duloxetine (DRUG), Intra-Articular Injection (COMBINATION_PRODUCT), Nerve Procedure with long acting blocks (PROCEDURE), Nerve Procedure with nerve ablation (PROCEDURE), Pain Coping Skills Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04504812?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.